الصحة والعلوم الشرق الأوسط
Dembele Criticizes Teammates at Halftime in France vs. Spain Match, Receives Harsh Response
Two Minutes a Day of Puzzles Is an Effective Way to Maintain Brain Health
Northern Iran at risk of American strikes
Is high cortisol levels truly the "enemy" everyone's fear?
Why does Messi wear a "Jewish" bracelet before England matches?
المصدر: الصحة والعلوم الشرق الأوسط
10 Hrsجاهز للتشغيل
جاهز للتشغيل
The article discusses a new class of medications for gastroesophageal reflux disease (GERD) known as "Potassium-Competitive Acid Blockers" or "P-Caps," as an effective alternative to traditional treatments. It explains that the drug "Vonoprazan" (Vokizna), available by prescription in the United States, is used to treat erosive esophagitis, non-erosive acid reflux, refractory stomach ulcers, and Helicobacter pylori bacterial infections. "P-Caps" medications are characterized by their rapid action and ability to maintain stable stomach pH levels throughout the day. They achieve this by blocking the potassium molecule essential for acid pump function, rather than activating it. Although they have shown greater efficacy compared to proton pump inhibitors (PPIs), the current barriers include limited long-term data and cost. Nevertheless, they represent a promising alternative for patients with severe and recurrent reflux conditions.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading